Global Collaborations Existing collaborations with Tokyo University of Science, Biosys Technologies, and St. Marianna University in Japan indicate market receptivity to joint development programs. These relationships can be leveraged to land new regional distributors and co-funded studies, accelerating geographic expansion in Asia and beyond.

Targeted Markets SKi Pro's label-free kinetics and KD measurement capabilities align with needs in therapeutic antibody development, affinity maturation, epitope mapping, and biomarker discovery. Focus sales outreach on pharma/biotech R&D labs, contract research organizations, and diagnostic developers seeking fast, quantitative interaction analysis.

Lean Growth With a small team and revenue in the low millions, Silicon Kinetics can scale through channel partnerships, distributors, and co-marketed services. Propose reseller agreements, integrated training packages, and joint marketing to broaden reach without a large direct sales force.

Competitive Differentiation Porous silicon biosensors enabling sensitive, label-free analysis complemented by affinity capture mass spectrometry positions SKi Pro to differentiate from fluorescence- or label-based platforms. Emphasize fast primary screening and deep kinetic characterization to win antibody and small-molecule discovery projects.

Expansion Opportunities Consumables and services expansion potential alongside instrument sales. Explore method development collaborations, training, and on-site demonstrations; cross-sell into related analytical equipment vendors or CRO networks to increase attach rate and life-cycle revenue.